Cancer Vaccine Stops Melanoma Return in Major Trial

A personalized cancer vaccine has stopped deadly skin cancer from returning in patients, marking what scientists call a pivotal breakthrough in treatment.

The experimental jab uses the same mRNA technology that powered COVID vaccines to target cancer cells.